These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7153101)

  • 21. Iododeoxyuridine radiosensitization by low- and high-energy photons for brachytherapy dose rates.
    Nath R; Bongiorni P; Rockwell S
    Radiat Res; 1990 Dec; 124(3):249-58. PubMed ID: 2263725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiolabeled nucleoside analogs in cancer diagnosis and therapy.
    Kassis AI; Adelstein SJ; Mariani G
    Q J Nucl Med; 1996 Sep; 40(3):301-19. PubMed ID: 8961807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinetics of uptake, retention, and radiotoxicity of 125IUdR in mammalian cells: implications of localized energy deposition by Auger processes.
    Kassis AI; Sastry KS; Adelstein SJ
    Radiat Res; 1987 Jan; 109(1):78-89. PubMed ID: 3809393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radioprotection against lethal damage caused by chronic irradiation with radionuclides in vitro.
    Howell RW; Goddu SM; Bishayee A; Rao DV
    Radiat Res; 1998 Oct; 150(4):391-9. PubMed ID: 9768852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic application of iodine-125 labeled iododeoxyuridine in an early ascites tumour model.
    Bloomer WD; Adelstein SJ
    Curr Top Radiat Res Q; 1978 Jan; 12(1-4):513-25. PubMed ID: 639561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The question of relative biological effectiveness and quality factor for auger emitters incorporated into proliferating mammalian cells.
    Howell RW; Rao DV; Hou DY; Narra VR; Sastry KS
    Radiat Res; 1991 Dec; 128(3):282-92. PubMed ID: 1961925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential future application with therapeutic agents.
    Atkins HL
    Semin Nucl Med; 1979 Apr; 9(2):121-30. PubMed ID: 482948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutagenic and lethal effects of [5-125I]iodo-2'-deoxyuridine incorporated into DNA of mammalian cells, and their RBEs.
    Miyazaki N; Fujiwara Y
    Radiat Res; 1981 Dec; 88(3):456-65. PubMed ID: 7313075
    [No Abstract]   [Full Text] [Related]  

  • 29. 5-123I/125I-iodo-2'-deoxyuridine for cancer diagnosis and therapy.
    Kassis AI
    J Nucl Med Allied Sci; 1990; 34(4):299-303. PubMed ID: 2090794
    [No Abstract]   [Full Text] [Related]  

  • 30. Radioiododeoxyuridine in cancer therapy: an in vitro approach to developing in vivo strategies.
    Schneiderman MH; Schneiderman GS
    J Nucl Med; 1996 Apr; 37(4 Suppl):6S-9S. PubMed ID: 8676203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemical modification of 5-[125I]iodo-2'-deoxyuridine toxicity in mammalian cells in vitro.
    Walicka MA; Adelstein SJ; Kassis AI
    Int J Radiat Biol; 2001 May; 77(5):625-30. PubMed ID: 11382341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A cell kinetic method for the mitotic selection of treated G2 cells.
    Schneiderman MH; Schneiderman GS; Rusk CM
    Cell Tissue Kinet; 1983 Jan; 16(1):41-9. PubMed ID: 6825155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Photon activation therapy.
    Fairchild RG; Bond VP
    Strahlentherapie; 1984 Dec; 160(12):758-63. PubMed ID: 6515666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strategies for selective targeting of Auger electron emitters to tumor cells.
    O'Donoghue JA
    J Nucl Med; 1996 Apr; 37(4 Suppl):3S-6S. PubMed ID: 8676202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incorporation of 5-iododeoxyuridine 1311 in spontaneous C3H mouse mammary tumours.
    ROTENBERG AD; BRUCE WR; BAKER RG
    Br J Radiol; 1962 May; 35():337-42. PubMed ID: 14494361
    [No Abstract]   [Full Text] [Related]  

  • 36. The use of non-hypoxic cell sensitizers in radiobiology and radiotherapy.
    Mitchell JB; Russo A; Kinsella TJ; Glatstein E
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1513-8. PubMed ID: 3531118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiolabeled IUdR. Proceedings of a meeting. Boston, Massachusetts, October 4, 1994.
    J Nucl Med; 1996 Apr; 37(4 Suppl):1S-32S. PubMed ID: 8676194
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacokinetics and dosimetry of iodine-125-IUdR in the treatment of colorectal cancer metastatic to liver.
    Daghighian F; Humm JL; Macapinlac HA; Zhang J; Izzo J; Finn R; Kemeny N; Larson SM
    J Nucl Med; 1996 Apr; 37(4 Suppl):29S-32S. PubMed ID: 8676201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of halogenated thymidine analogs as clinical radiosensitizers: rationale, current status, and future prospects: non-hypoxic cell sensitizers.
    Kinsella TJ; Mitchell JB; Russo A; Morstyn G; Glatstein E
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1399-406. PubMed ID: 6381432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thermally enhanced radioresponse of cultured Chinese hamster cells: inhibition of repair of sublethal damage and enhancement of lethal damage.
    Ben-Hur E; Elkind MM; Bronk BV
    Radiat Res; 1974 Apr; 58(1):38-51. PubMed ID: 10876605
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.